New AI makes drug discovery faster and cheaper.
Drug discovery is traditionally slow and costly, but Waterloo researchers are changing the game. By working across disciplines and harnessing machine learning, their generative AI model, Imagand, rapidly analyzes how new drugs interact in the body and with existing medications. This powerful tool makes drug discovery faster, cheaper and more precise, accelerating the path to new therapies. Read more.
Personalized treatment is the next frontier in medicine. Machine learning research like this is putting that treatment in the hands of everyone.
Dr. Helen Chen (Public Health, Statistics, and Computer Science), Bing Hu (PhD, Computer Science), and Dr. Anita Layton (Canada Research Chair, Mathematical Biology) are interdisciplinary researchers at the University of Waterloo. They use modeling, simulation and analysis to develop innovative solutions at the intersection of human health, mathematics, and technology.
Explore more ways Waterloo is on it.
Cutting energy with code →
Explore how Waterloo researchers are developing code that may cut data centre energy use by 30%.
Reducing fleet emissions →
Discover how this Waterloo student is reducing Purolator's fleet emissions.
Boost your knowledge. Subscribe to rich content.
Quick knowledge, big insights! Subscribe to the Innovation Insider for health, climate, tech, physics and human behaviour innovations in under two minutes.